James J. Egan
Geen lopende functies
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Robert Funck | M | 62 | 37 jaar | |
Scott House | M | - | 34 jaar | |
Adel Moussa | M | - | 22 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Tom R. Hodgson | M | 82 | 12 jaar | |
Richard de Schutter | M | 83 |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | 4 jaar |
Elaine R. Leavenworth | F | 65 | 27 jaar | |
Daniel P. Getman | M | 68 | - | |
Dipak Panigrahi | M | - | - | |
G. Kirk Raab | M | 88 | 4 jaar | |
William Ashton | M | 73 | 6 jaar | |
Andrew J. Ferrara | M | 84 | 3 jaar | |
Peter Lichtlen | M | 56 |
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | 9 jaar |
Wayne T. Hockmeyer | M | 79 | - | |
Duane L. Burnham | M | 82 | 9 jaar | |
H. Fuller | M | 85 | - | |
Andrew P. Smith | M | 61 | 6 jaar | |
Denise Scots-Knight | M | 64 | 11 jaar | |
Steven M. Rauscher | M | 70 | 18 jaar | |
James Young | M | - | 33 jaar | |
Jack Schuler | M | 83 | 17 jaar | |
Mary Szela | F | 60 | 25 jaar | |
Thomas Joseph Dee | M | 60 | 23 jaar | |
Thomas Knapp | M | 71 | 5 jaar | |
Charles W. Cramb | M | 77 | 9 jaar | |
David Arkowitz | M | 62 | 4 jaar | |
Michael Carter | M | - | - | |
S. Ken Tanaka | M | 72 | - | |
Keith Maynard Lingenfelter | M | - | 12 jaar | |
Mark McCamish | M | 72 | 7 jaar | |
Martin Gertsch | M | 59 |
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | 2 jaar |
David Stamler | M | 63 | 4 jaar | |
Douglas Liu | M | 62 | 10 jaar | |
John R. Tushar | M | 62 | - | |
Michael Fiechtner | M | - | 12 jaar | |
Michael Williams | M | - | 11 jaar | |
Joe R. Sanders | M | - | 10 jaar | |
Gary Stevenson | M | - | 7 jaar | |
R. James Danehy | M | - | 21 jaar | |
Bill Welch | M | 62 | 5 jaar | |
Ian McLeod | M | - | 3 jaar | |
Matt van Bergen | M | - | 2 jaar | |
Brian L. Durkin | M | 63 | 30 jaar | |
Sharon Larkin | F | 60 | 23 jaar | |
Robert Michael | M | 53 | 19 jaar | |
Louise Dube | M | - | 14 jaar | |
Karen Peterson | F | - | 30 jaar | |
Brian Fenton | M | 57 | 5 jaar | |
Keith Pietropaolo | M | - | 11 jaar | |
Terry Opgenorth | M | 68 | 20 jaar | |
Anthony Barnes | M | 69 | 2 jaar | |
Lisa Giles | F | 65 | 10 jaar | |
Silvia Taylor | F | - | 6 jaar | |
Chris M. Kolber | M | - | 14 jaar | |
Christopher Rovaldi | M | 50 | 3 jaar | |
Azita Saleki-Gerhardt | M | 60 | 19 jaar | |
Corlis D. Murray | F | - | 31 jaar | |
Anne Schmidt | M | - |
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | - |
Cary Claiborne | M | 64 | 3 jaar | |
Shawn M. Marcell | M | 62 | 7 jaar | |
Fang-Tyan Chen | M | 74 | 22 jaar | |
Pamela Thomas-Graham | F | 60 | 5 jaar | |
Susan L. Koppy | F | 62 | 1 jaar | |
Jean-Yves F. Pavée | M | 60 | - | |
Carlos Alban | M | 61 | 26 jaar | |
Jan Smilek | M | 57 | 3 jaar | |
Joseph G. Darling | M | 66 | 7 jaar | |
Shi-Chung Ng | M | 69 | 11 jaar | |
Luke Seikkula | M | 60 | 10 jaar | |
Irene C. Kerr | F | 74 | 10 jaar | |
Robert Karr | M | 75 |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | 8 jaar |
Timothy Ring | M | 66 | 10 jaar | |
Gregory Deener | M | 62 | - | |
H. Watkins | M | 71 | 19 jaar | |
Robert E. Pelzer | M | 70 | 9 jaar | |
Holger Liepmann | M | 72 | 25 jaar | |
George F. Horner | M | 80 | 17 jaar | |
John Walter | M | 76 | 17 jaar | |
Gary P. Coughlan | M | 80 | 11 jaar | |
Christopher Kuebler | M | 70 | 8 jaar | |
Boone Powell | M | 87 | - | |
Peter S. DiStefano | M | 66 | 5 jaar | |
Eric Adams | M | 61 | 4 jaar | |
Edward Michael | M | 66 | - | |
John Leonard | M | 66 | 20 jaar | |
Edward Fiorentino | M | 65 | - | |
Mark Miller | M | 68 | 16 jaar | |
Yat Sun Or | M | 72 | 14 jaar | |
Paul Edick | M | 67 |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | 8 jaar |
Todd Davis | M | 63 | 5 jaar | |
Guy MacDonald | M | 65 | 5 jaar | |
Joy Amundson | F | 69 | 16 jaar | |
Thomas O. Hecht | M | 73 |
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | 5 jaar |
Susan Rodriguez | F | 60 | 24 jaar | |
Thomas Ebeling | M | 65 | - | |
Alan S. Rosenthal | M | - | 6 jaar | |
Philippe G. Prokocimer | M | 74 | 7 jaar | |
Christopher Begley | M | 71 | 18 jaar | |
O. Ralph Edwards | M | 89 | - | |
Paul D. Rubin | M | 70 | 6 jaar | |
Jeffrey Stewart | M | - | - |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 97 | 97.00% |
Zwitserland | 4 | 4.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- James J. Egan
- Persoonlijk netwerk